N6-methyladenosine contributes to cellular phenotype in a genetically-defined model of breast cancer progression

MLA

Olga Ilkayeva, et al. “N6-Methyladenosine Contributes to Cellular Phenotype in a Genetically-Defined Model of Breast Cancer Progression.” Oncotarget, vol. 9, July 2018, pp. 31231–43. EBSCOhost, https://doi.org/10.18632/oncotarget.25782.

APA

Olga Ilkayeva, Kyle D. Mansfield, Kristen Carraway, Nate J. Fry, Christopher L. Holley, & Brittany A. Law. (2018). N6-methyladenosine contributes to cellular phenotype in a genetically-defined model of breast cancer progression. Oncotarget, 9, 31231–31243. https://doi.org/10.18632/oncotarget.25782

Chicago

Olga Ilkayeva, Kyle D. Mansfield, Kristen Carraway, Nate J. Fry, Christopher L. Holley, and Brittany A. Law. 2018. “N6-Methyladenosine Contributes to Cellular Phenotype in a Genetically-Defined Model of Breast Cancer Progression.” Oncotarget 9 (July): 31231–43. doi:10.18632/oncotarget.25782.